Skip to content
healthcare.dev

CHLORASEPTIC

NDC 67172-021, menthol and benzocaine, lozenge, from Prestige Brands Holdings, Inc..

Product NDC
67172-021
Status
Listed
Labeler
Prestige Brands Holdings, Inc.
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M022
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67172-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MENTHOL10 mg/1
  • BENZOCAINE6 mg/1

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
67172-021-18671720021181 BLISTER PACK in 1 CARTON (67172-021-18) / 18 LOZENGE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 67172-021 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67172-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67172-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.